Nanomedic Technologies

Executive Summary

Nanomedic Technologies develops and commercializes the Spincare System, a portable electrospinning device that creates a personalized nanofibrous skin-like layer for advanced wound care. Targeting burns, chronic wounds, and dermatological applications, the company addresses a significant unmet need in wound management, where traditional treatments often fail to provide adequate healing or infection control. The Spincare System’s key advantage lies in its portability and ability to produce a custom, conformable matrix in situ, enabling rapid and effective wound coverage without the need for external dressings. Since its founding in 2018, Nanomedic has advanced to commercial stage, indicating early market traction and validation. The company is headquartered in Tel Aviv, Israel, and operates with a team of 50–200 employees, positioning it as a nimble innovator in the medtech space. With a growing global burden of acute and chronic wounds, Nanomedic is well-placed to capture market share, particularly in settings requiring quick, sterile, and easy-to-apply wound solutions. The company’s technology has the potential to reduce treatment costs, prevent infections, and improve patient outcomes, driving adoption in hospitals, clinics, and field medicine.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for Spincare System in the US75% success
• Q4 2026Strategic distribution partnership for European market expansion65% success
• Q2 2026Publication of clinical trial results for diabetic foot ulcers demonstrating superior healing rates80% success